Global Tricuspid Valve Repair Market Seeks Prosperous Horizon: Anticipating a US$2.5 Bn market

BRUSSELS - Jan. 8, 2024 - PRLog -- One of the four valves in our heart that regulates blood flow is the tricuspid valve (https://meditechinsights.com/tricuspid-valve-repair-market/). It is located between the ventricle and the atrium, the upper and lower chambers of our heart, on the right side. It guarantees that blood travels from the right atrium to the right ventricle in the proper path. As blood passes through the tricuspid valve, its three leaflets, or flaps, open and close.

Growth in Tricuspid Regurgitation Management Drives the Tricuspid Valve Repair Market

The most frequent sign that the tricuspid valve has to be repaired is tricuspid regurgitation, or TR. Approximately 1.6 million Americans suffer from moderate to severe tricuspid regurgitation; by comparison, only a small number of tricuspid valve repair surgeries are carried out each year. The majority of the patients in this demographic are older and have abdominal swelling, peripheral oedema, weariness, and a low tolerance for exertion. Conservative medications, such as high-dose diuretics, are needed to manage these symptoms, although they have little therapeutic impact.

Tricuspid Valve Repair Market: Trends

Some of the emerging trends in the tricuspid valve repair market are:

Transcatheter Approaches:

• In September 2022, Cardiac Implant LLC, announced the successful initial deployment of its Annuloplasty ring with the implementation of a therapeutic adjustment procedure using its innovative Tri-Ring™ percutaneous annuloplasty device

Clip Technologies:

• In May 2023, Abbott released late-breaking data that adds to the body of clinical evidence demonstrating the advantages of the TriClip transcatheter edge-to-edge repair (TEER) device in the treatment of patients with leaking tricuspid valves

North America controls the majority of the Global Tricuspid Valve Repair Market

North America has emerged as the global leader in tricuspid valve repair. The region is experiencing significant market growth, which is being driven by stringent favorable regulatory environments for the approval and commercialization of innovative tricuspid valve repair devices, an increase in the prevalence of cardiovascular diseases.

Tricuspid Valve Repair Market: Competitive Landscape

Edwards Lifesciences Corp., Abbott, Medtronics, Corcym, Labcor, Valtech Cardio Ltd., Sorin S.p.A., CroiValve, FOLDAX, Cardia Implant LLC, LivaNova PLC, Cyberonics Inc., Boston Scientific Corporation, Micro Interventional Devices Inc., 4Tech Inc., among others.

The tricuspid valve repair business is a fast-paced, ever-changing industry. The market is predicted to expand due to developments in transcatheter tricuspid valve repair technology, expanding clinical studies, and aggressive organic and inorganic growth tactics employed by industry participants.

Get Detailed Insights on the Tricuspid Valve Repair Market @ https://meditechinsights.com/tricuspid-valve-repair-market/